bw 373u86 has been researched along with alfentanil in 1 studies
Studies (bw 373u86) | Trials (bw 373u86) | Recent Studies (post-2010) (bw 373u86) | Studies (alfentanil) | Trials (alfentanil) | Recent Studies (post-2010) (alfentanil) |
---|---|---|---|---|---|
80 | 0 | 4 | 1,731 | 757 | 172 |
Protein | Taxonomy | bw 373u86 (IC50) | alfentanil (IC50) |
---|---|---|---|
Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0389 | |
Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.015 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, KJ; McNutt, RW; Su, YF | 1 |
1 other study(ies) available for bw 373u86 and alfentanil
Article | Year |
---|---|
Delta-opioid ligands reverse alfentanil-induced respiratory depression but not antinociception.
Topics: Alfentanil; Analgesics, Opioid; Animals; Benzamides; Hypercapnia; Ligands; Male; Naltrexone; Narcotic Antagonists; Narcotics; Oligopeptides; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Receptors, Opioid, mu; Respiration; Respiratory Insufficiency; Somatostatin | 1998 |